Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quintiles Outsources CEO: Roche Exec Pamela Kirby Joins CRO April 2

Executive Summary

Quintiles CEO-designate Pamela Kirby, PhD, will look to sustain the contract research organization's operating turnaround while navigating through a difficult period in its relationship with WebMD/Envoy.
Advertisement

Related Content

Quintiles Rejects Buy-Out Offer From Founder Gillings, Weighs Options
Quintiles Rejects Buy-Out Offer From Founder Gillings, Weighs Options
Covance Manufacturing Divestment To Fund $20 Mil. Toxicology Expansion
Covance Manufacturing Divestment To Fund $20 Mil. Toxicology Expansion
CDC Bio-Terrorism Effort Relies On Access To Envoy Data, Quintiles Says
CDC Bio-Terrorism Effort Relies On Access To Envoy Data, Quintiles Says
Roche U.S. McKinsey Review Will Complete "Diagnostic" Phase In April
CDC Bio-Terrorism Effort Relies On Access To Envoy Data, Quintiles Says
Quintiles To Invest $50-$100 Mil. In "Non-Traditional" Outsourcing Deals
Advertisement
UsernamePublicRestriction

Register

PS037526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel